Dermata Therapeutics, Inc. Logo

Dermata Therapeutics, Inc.

Medical dermatology company developing and commercializing OTC skin care products.

DRMA | US

Overview

Corporate Details

ISIN(s):
US2498451085
LEI:
Country:
United States of America
Address:
3525 DEL MAR HEIGHTS RD., #322, 92130 SAN DIEGO

Description

Dermata Therapeutics is a medical dermatology company that has shifted its strategic focus to developing and commercializing scientifically-backed over-the-counter (OTC) pharmaceutical products. The company leverages its proprietary Spongilla technology, which combines natural elements with FDA-listed OTC ingredients to create differentiated skin care solutions. Its initial product is a once-weekly acne kit, supported by clinical validation from its Phase 3 START-1 trial. Dermata plans to expand its portfolio with product candidates for other common skin conditions, such as psoriasis and seborrheic dermatitis, aiming to provide patients with accessible and effective treatments to manage their skin health.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Dermata Therapeutics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Dermata Therapeutics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Dermata Therapeutics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Forte Biosciences, Inc. Logo
A clinical-stage biopharma firm developing treatments for autoimmune-related diseases.
United States of America
FBRX
Fortress Biotech, Inc. Logo
Biopharmaceutical firm that develops and commercializes a diversified drug portfolio.
United States of America
FBIO
FRACTYL HEALTH, INC. Logo
Develops therapies targeting the root causes of obesity and type 2 diabetes.
United States of America
GUTS
Friulchem Logo
A contract development and manufacturing organization for the animal health sector.
Italy
FCM
Fuji Pharma Co.,Ltd. Logo
Pharmaceutical firm focused on women's healthcare and contract manufacturing services.
Japan
4554
Fulcrum Therapeutics, Inc. Logo
Develops small molecule therapies for rare, genetically defined diseases.
United States of America
FULC
FunPep Company Limited Logo
Develops therapeutic solutions derived from functional peptides.
Japan
4881
Fuso Pharmaceutical Industries,Ltd. Logo
Develops and manufactures pharmaceuticals, focusing on infusions and dialysis solutions.
Japan
4538
FUTURA MEDICAL PLC Logo
Pharmaceutical company developing topical gel formulations for sexual health.
United Kingdom
FUM
FutureChem Co., Ltd. Logo
Develops radiopharmaceuticals and synthesis equipment for diagnostics and therapy.
South Korea
220100

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.